Skip to main content
Clinical Trials/DRKS00025457
DRKS00025457
Recruiting
未知

Major depression as a metabolic disorder: The role of oxygen homeostasis and mitochondrial bioenergetics in depression etiology and therapy - MitO2Health

Department of Clinical and Biological Psychology, Ulm University0 sites300 target enrollmentJuly 6, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
F32
Sponsor
Department of Clinical and Biological Psychology, Ulm University
Enrollment
300
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 6, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Clinical and Biological Psychology, Ulm University

Eligibility Criteria

Inclusion Criteria

  • A diagnosis of major depressive disorder according to DSM\-5; accepted psychological comorbidities: anxiety disorders, and somatoform disorders. Stable medication is permitted.

Exclusion Criteria

  • High suicidality, PTSD and complex PTSD, Borderline personality disorder, eating disorders, obsessive compulsive disorder, bipolar disorder, schizophrenia or a history of psychotic disorders, acute substance\-related disorder, organic mental disorder, pregnancy and nursing, neurological diseases, immunological and endocrine disorders, autoimmune diseases such as chronic viral infections, rheumatoid arthritis, cardiovascular comorbidities, cancer, chronic obstructive pulmonary diseases, Body Mass Index (BMI) \> 30, usage of certain intrauterine devices (eg. Mirena)

Outcomes

Primary Outcomes

Not specified

Similar Trials